Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: Omega-3 supplements are popular for cardiovascular disease (CVD) prevention. We aimed to assess the association between dose-specific omega-3 supplementation and CVD outcomes. Design: We included double-blind randomised clinical trials with duration ≥1 year assessing omega-3 supplementation and estimated the relative risk (RR) for all-cause mortality, cardiac death, sudden death, myocardial infarction and stroke. Primary analysis was a stratified random-effects meta-analysis by omega-3 dose in 4 a priori defined categories (<1, 1, 2, ≥3 of 1 g capsules/day). Complementary approaches were trial sequential analysis and sensitivity analyses for triglycerides, prevention setting, intention-to-treat analysis, eicosapentaenoic acid, sample size, statin use, study duration. Results: Seventeen studies (n=83 617) were included. Omega-3 supplementation as ≤1 capsule/day was not associated with any outcome under study; futility boundaries were crossed for all-cause mortality and cardiac death. For two capsules/day, we observed a statistically significant reduction of cardiac death (n=3, RR 0.55, 95% CI 0.33 to 0.90, I 2=0%); for ≥3 capsules/day we observed a statistically significant reduction of cardiac death (n=3, RR 0.82, 95% CI 0.68 to 0.99, I 2=0%), sudden death (n=1, RR 0.70, 95% CI 0.51 to 0.97) and stroke (n=2, RR 0.74, 95% CI 0.57 to 0.95, I 2=0%). Conclusion: Omega-3 supplementation at <2 1 g capsules/day showed no association with CVD outcomes; this seems unlikely to change from future research. Compared with the robust scientific evidence available for low doses, the evidence for higher doses (2–4 1 g capsules/day) is weak. The emerging postulated benefit from high-dose supplementation needs replication and further evaluation as to the precise formulation and indication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Particularly, effects on coronary revascularization are unclear”
From Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis (2024) · cites this paper as [41]
In the citing paper
“However, meta-analyses of omega-3 trials, whilst assessing major cardiovascular events, have paid no or little attention to the effects on coronary revascularizations.”
From Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis (2024) · cites this paper as [41]
Citations
Cites
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
Research works printed but not linked: 12
- 10.1001/2012.jama.11374 · DOI · Paper page
- Aung, 2018, Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals, JAMA Cardiol, 3, 225, 10.1001/jamacardio.2017.5205 · DOI · Paper page
- 10.1016/j.jacc.2012.11.021 · DOI
- 10.1097/HJR.0b013e328339cc70 · DOI · Paper page
- 10.1159/000207441 · DOI · Paper page
- Nilsen, 2001, Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol, Am J Clin Nutr, 74, 50, 10.1093/ajcn/74.1.50 · DOI · Paper page
- 10.7326/0003-4819-130-7-199904060-00003 · DOI · Paper page
- 10.1016/S0261-5614(98)80318-X · DOI
- 10.1016/0735-1097(95)00095-L · DOI · Paper page
- 10.1023/A:1007757724505 · DOI · Paper page
- Qato, 2016, Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011, JAMA Intern Med, 176, 473, 10.1001/jamainternmed.2015.8581 · DOI · Paper page
- 10.1161/JAHA.113.000506 · DOI · Paper page
Cited by
Fu, Y., Wang, Y., Gao, H., Li, D., Jiang, R., Ge, L., Tong, C., & Xu, K. (2021) · Mediators of Inflammation · doi:10.1155/2021/8879227 · Cited by 343
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis
Lok, C. E., Farkouh, M., Hemmelgarn, B. R., Moist, L. M., Polkinghorne, K. R., Tomlinson, G., Tam, P., Tonelli, M., & Udell, J. A. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2513032 · Cited by 60
Shen, S., Gong, C., Jin, K., Zhou, L., Xiao, Y., & Ma, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.809311 · Cited by 59
Dinu, M., Sofi, F., Lotti, S., Colombini, B., Mattioli, A. V., Catapano, A. L., Casula, M., Baragetti, A., Wong, N. D., Steg, P. G., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae184 · Cited by 43
Markozannes, G., Ntzani, E. E., Tsapas, A., Mantzoros, C. S., Tsiara, S., Xanthos, T., Karpettas, N., Patrikios, I., & Rizos, E. C. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.022 · Cited by 16
Self-citation
Metadata
- Authors
- Rizos, E. C., Markozannes, G., Tsapas, A., Mantzoros, C. S., & Ntzani, E. E.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2020-08-20
- Volume
- 107
- Issue
- 2
- Pages
- 150-158
- ISSN
- 1355-6037
- 1468-201X
- Cited by
- 39
- References
- 16
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis. https://app.cochat.ai/papers/10.1136/heartjnl-2020-316780
- The paper
- Rizos, E. C., Markozannes, G., Tsapas, A., Mantzoros, C. S., & Ntzani, E. E. (2021). Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis. Heart. https://doi.org/10.1136/heartjnl-2020-316780
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.